查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1424356

微生物原料藥的全球市場：按宿主、按類型、按最終用戶、按地區

Global Microbial API Market, By Host, By Type, By End User, By Region
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

微生物原料藥的全球市場規模預計將從 2023 年的 612.1 億美元增至 2030 年的 961.1 億美元，預測期內複合年成長率為 6.7%。

報告範圍 報告詳情
基準年 2022年 2023/2024年市場規模 612.1億美元
實際資料 2018-2021 預測期 2023-2030
預測期間 2023/2024 至 2030/2031 年複合年成長率： 6.70% 2030/2031價值預測 961.1億美元
圖 1. 微生物源 API 的全球市場佔有率（%），按地區分類，2023 年
全球微生物原料藥市場-IMG1

微生物原料藥是指利用細菌、真菌、酵母等各種微生物經由微生物發酵生產的治療物質或原料原料藥。微生物原料藥主要有兩大類：低分子原料藥和高分子原料藥。小分子原料藥是小分子治療物質，通常透過化學合成生產。大分子原料藥，俗稱生技藥品，是透過重組DNA技術或受管制微生物發酵生產的複雜治療物質，如單株抗體、疫苗、血液因子等。

大分子微生物原料藥與小分子原料藥相比具有一定的優點。標靶特異性高、毒性低，對癌症、糖尿病等慢性疾病有較好的治療效果。此外，使用活微生物的聚合微生物製劑的製造過程可以靈活生產與個人化醫療相容的各種產品。

市場動態：

由於成本效益，對學名藥的需求不斷成長，推動了全球微生物原料藥市場。此外，微生物發酵在反應特異性、生產率和產率方面比化學合成具有優勢，促使製藥公司加大對微生物原料藥生產的投資。然而，建立和開發微生物發酵設施以及擴大聚合微生物原料藥的生產流程的高資本要求是複雜且資本集中的，以及嚴格的監管流程，這些都是預計限制成長的一些因素。

降低製造成本的創新發酵技術的發展為微生物原料藥製造商提供了利潤豐厚的機會。此外，作為生物製品，除非在嚴格的品管下生產，否則很容易出現雜質和批次間的差異。這增加了大分子微生物原料藥的監管障礙並增加了商品成本。

按地區分類，北美由於醫療費用高且獲得良好的醫療服務而佔據市場主導地位。然而，在中國和印度等國家的推動下，亞太地區是成長最快的市場。這一成長歸因於經濟成長、可支配收入增加、醫療基礎設施擴大以及生技藥品需求增加。

本研究的主要特點

  • 該報告對全球微生物原料藥市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
  • 它還闡明了各個細分市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球微生物活性原料藥市場的主要企業。
  • 該報告的見解將使行銷人員和經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略負責人明智的決策。
  • 全球微生物原料藥市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球微生物原料藥市場的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第 3 章 關鍵產業見解

  • 市場動態
  • 促進因素
  • 抑制因素
  • 機會
  • 影響分析
  • PEST分析
  • 波特的分析
  • 技術進步
  • 合併、收購和合作場景
  • 最近的產品核准/發布
  • 公司市場佔有率分析

第4章 全球微生物原料藥市場（依主辦單位）2018-2030 年

  • 哺乳動物的
  • 細菌
  • 菌

第5章全球微生物原料藥市場，依類型，2018-2030

  • 抗體
  • 胜肽
  • 蛋白質
  • 低分子
  • 疫苗

第 6 章 全球微生物原料藥市場，依地區分類，2018-2030 年

  • 公司內部
  • 外包

第7章 全球微生物原料藥市場，依最終使用者分類，2018-2030 年

  • 製藥公司年份
  • 生物製藥公司年份
  • 其他

第8章全球微生物原料藥市場，依分子，2018-2030

  • 新藥
  • 非專利的

第9章2018-2030年全球微生物原料藥市場（按地區）

  • 按地區
  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章公司簡介-微生物原料藥市場

  • KOLON LIFE SCIENCE
    • 公司簡介
    • 產品/服務組合
    • 財務績效
    • 最新動態/最新訊息
    • 策略概覽
  • Shandong Lukang Pharmaceutical Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Lonza
  • Merck & Co., Inc.
  • Topfond Pharmaceutical Co., Ltd.
  • DSM
  • CSPC Pharmaceutical Group Limited

第11章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI6508

The global microbial API market size is expected to reach US$ 96.11 Bn by 2030, from US$ 61.21 Bn in 2023, at a CAGR of 6.7% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023/2024: US$ 61.21 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR: 6.70% 2030/2031 Value Projection: US$ 96.11 Bn
Figure 1. Global Microbial API Market Share (%), by Region, 2023
Global Microbial API Market - IMG1

Microbial APIs refer to therapeutic substances or active pharmaceutical ingredients produced through microbial fermentation using various microorganisms such as bacteria, fungi, or yeast. There are mainly two types of microbial APIs: small molecule APIs and large molecule APIs. Small molecule APIs are low-molecular-weight therapeutic substances that are usually produced through chemical synthesis. Large molecule APIs, commonly known as biologics, are complex therapeutic substances like monoclonal antibodies, vaccines, blood factors, etc. that are produced by recombinant DNA technology or controlled microbial fermentation.

Large molecule microbial APIs have certain advantages over small molecule APIs. Due to their high target specificity and lower toxicity, they provide better treatment outcomes for chronic diseases like cancer, diabetes, etc. The manufacturing process of large molecule microbial APIs using living microbes also allows for flexible production of a wide range of product variants catering to personalized medicine.

Market Dynamics:

The global microbial API market is driven by the rising demand for generic and biosimilar drugs owing to cost efficiency. Moreover, microbial fermentation offers advantages over chemical synthesis in terms of reaction specificity, productivity, and yields, which is encouraging pharmaceutical manufacturers to increase investment in microbial API production. However, the high capital requirement for setting up microbial fermentation facilities, developing, and scaling up the manufacturing process of large molecule microbial APIs is complex and capital-intensive and stringent regulatory processes are some of the factors expected to restrain market growth.

The development of innovative fermentation technologies to decrease production costs presents lucrative opportunities for microbial API manufacturers. Additionally, being biological products, they are more prone to impurities and batch-to-batch inconsistencies if not manufactured under stringent quality controls. This raises regulatory hurdles and the cost of goods for large molecule microbial APIs.

Among regions, North America dominates the market due to high healthcare expenditures and better access to care. However, Asia Pacific is poised to be the fastest-growing market arena, led by countries like China and India. This growth can be attributed to growing economies, rising disposable incomes, expanding medical infrastructure, and increasing demand for biologics.

Key features of the study:

  • This report provides in-depth analysis of the global microbial API market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global microbial API market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Merck & Co., Inc., Topfond Pharmaceutical Co., Ltd., DSM, CSPC Pharmaceutical Group Limited., KOLON LIFE SCIENCE, Teva Pharmaceutical Industries Ltd., Lonza, Akums Lifesciences Ltd., AbbVie Inc., Xellia Pharmaceuticals, BASF, Dr. Reddy's Laboratories and Lupin
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global microbial API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global microbial API market

Detailed Segmentation:

Global Microbial API Market

  • By Host
    • Mammalian
    • Bacterial
    • Fungal
  • By Type
    • Antibody
    • Peptide
    • Protein
    • Small Molecule
    • Vaccine
  • By Site
    • In-house
    • Outsourced
  • By End User
    • Pharmaceutical Companies
    • Biopharmaceutical Companies
    • Others
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Top companies in Global Microbial API Market:
    • Merck & Co., Inc.
    • Topfond Pharmaceutical Co., Ltd.
    • DSM
    • CSPC Pharmaceutical Group Limited.
    • KOLON LIFE SCIENCE
    • Teva Pharmaceutical Industries Ltd.
    • Lonza
    • Akums Lifesciences Ltd.
    • AbbVie Inc.
    • Xellia Pharmaceuticals
    • BASF
    • Reddy's Laboratories
    • Lupin

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Top 3 Market Findings
    • Top 3 Market Opportunity

3. Key Industry Insights

  • Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
  • Impact Analysis
  • Pest Analysis
  • Porters Analysis
  • Technological Advancement
  • Merger, Acquisition and Collaboration Scenario
  • Recent Product Approvals/Launches
  • Company Market Share Analysis

4. Global Microbial API Market, By Host, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • Mammalian, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Bacterial, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Fungal, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

5. Global Microbial API Market, By Type, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • Antibody, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Peptide, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Protein, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Small Molecule, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Vaccine, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

6. Global Microbial API Market, By Site, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • In-house, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Outsourced, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

7. Global Microbial API Market, By End user, 2018-2030, (US$ Bn)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • Pharmaceutical Companies, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Biopharmaceutical Companies, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Others, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

8. Global Microbial API Market, By Molecule, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • Innovative, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Generic, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

9. Global Microbial API Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • By Region
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • North America
    • Introduction
    • Market Size and Forecast, By Host, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Site, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End-use, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Molecule, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • U.S.
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Canada
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Europe
    • Introduction
    • Market Size and Forecast, By Host, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Site, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End-use, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Molecule, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • U.K
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Germany
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • France
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Italy
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Spain
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Russia
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Rest of Europe
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Host, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Site, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End-use, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Molecule, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • China
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • India
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Japan
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Australia
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • South Korea
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • ASEAN
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Rest of Asia Pacific
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Latin America
    • Introduction
    • Market Size and Forecast, By Host, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Site, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End-use, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Molecule, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • Brazil
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Mexico
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Argentina
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Rest of Latin America
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Middle East
    • Introduction
    • Market Size and Forecast, By Host, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Site, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End-use, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Molecule, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • GCC
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Israel
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Rest of Middle East
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Africa
    • Introduction
    • Market Size and Forecast, By Host, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Site, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End-use, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • North Africa
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Central Africa
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • South Africa
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

10. Company Profiles - Microbial API Market

  • KOLON LIFE SCIENCE*
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Shandong Lukang Pharmaceutical Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Lonza
  • Merck & Co., Inc.
  • Topfond Pharmaceutical Co., Ltd.
  • DSM
  • CSPC Pharmaceutical Group Limited

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact